{
  "actions": [
    {
      "acted_at": "2020-03-05",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2020-03-05",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6102-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "B001275",
      "district": "8",
      "name": "Bucshon, Larry",
      "original_cosponsor": true,
      "sponsored_at": "2020-03-05",
      "state": "IN",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-03-05",
  "number": "6102",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s3404-116",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "VALID Act of 2020",
  "sponsor": {
    "bioguide_id": "D000197",
    "district": "1",
    "name": "DeGette, Diana",
    "state": "CO",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-03-05",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Administrative remedies",
    "Advisory bodies",
    "Congressional oversight",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Emergency medical services and trauma care",
    "Federal preemption",
    "Food and Drug Administration (FDA)",
    "Government information and archives",
    "Health",
    "Health technology, devices, supplies",
    "Licensing and registrations",
    "Medical tests and diagnostic methods",
    "Performance measurement",
    "User charges and fees"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2020-03-05",
    "date": "2021-09-08T15:19:56Z",
    "text": "Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020\n\nThis bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition)."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "VALID Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "VALID Act of 2020",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Verifying Accurate Leading-edge IVCT Development Act of 2020",
      "type": "short"
    }
  ],
  "updated_at": "2022-02-08T23:16:10Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr6102.xml"
}